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Abstract  
 
Colorectal cancer (CRC) metastasis dissemination to secondary sites represents the critical point for the patient’s 
survival. The microenvironment is crucial to cancer progression, influencing tumour cell behaviour by modulating the 
expression and activation of molecules such as integrins, the cell-extracellular matrix interacting proteins participating 
in different steps of the tumour metastatic process. In this work, we investigated the role of 51 integrin and how the 
microenvironment influences this adhesion molecule, in a model of colon cancer progression to the liver. The culture 
medium conditioned by the IHH hepatic cell line, and the extracellular matrix (ECM) proteins, modulate the activation 
of 51 integrin in the colon cancer cell line HCT-116 and drives FAK phosphorylation during the process of cell 
adhesion to fibronectin, one of the main components of liver ECM. In these conditions, 51 modulates the 
expression/activity of another integrin, 21, involved in the cell adhesion to collagen I. 
These results suggest that 51 integrin holds a leading role in HCT-116 colorectal cancer cells adhesion to the ECM 
through the modulation of the intracellular focal adhesion kinase FAK and the 21 integrin activity. The driving role 
of the tumour microenvironment on CRC dissemination, here detected and described, strengthens and adds new value to 
the concept that 51 integrin can be an appropriate and relevant therapeutic target for the control of CRC metastases. 
This article is protected by copyright. All rights reserved 
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The microenvironment surrounding cancer cells acts as a functional entity inducing and responding to tumour and host 
factors
 
[Vidal-Vanaclocha, 2011; Schedin and Keely, 2011], and determining the colonization of invasive cells in 
particularly favourite organs [Weiss, 1992; Friedl and Wolf, 2003].  
Colon cancer frequently metastasizes to the liver. Anatomical/hemodynamic and functional/micro-environmental 
factors work together to trap circulating cancer cells into this site. The hepatic microenvironment may contribute to 
cancer cell retention, and facilitates the ability of some of them to grow in the liver as a metastasis. In fact, fenestrated 
endothelial cells and Kuppfer cells constitutively express a rich profile of surface oligosaccharides [Barbera-Guillem et 
al., 1991], cell adhesion proteins [Scoazec and Feldman, 1991]
 
and recognition receptors [Szabo et al., 1997] that 
account for an efficient hepatic uptake and clearance of cancer cells. Therefore, the liver induces colon cancer cells to 
express pro-metastatic receptors, and to secrete soluble factors which, in turn, cause remote activation of hepatic cells 
and pre-metastatic niches [Kaplan et al., 2006]. 
The extracellular matrix (ECM) constitutes the non-cellular part of the microenvironment, and its components regulate 
cell growth, migration and survival. At the same time, tumour cells need to remodel the ECM to create a nutrient rich 
milieu permitting their survival and growth. 
Cells use integrins to take advantage of the great amount of biological information coming from the ECM [Hynes, 
1992; Ruoslahti and Reed, 1994; Huhtala et al., 1995]. These cell surface adhesion receptors play a critical role also in 
tumour progression and metastasis, and alterations in their expression and/or activity influence the metastatic potential 
of tumour cells. 1 integrin is related to the malignant phenotype in breast cancer [Weaver et al., 1997; Jia et al., 2004], 
mediates drug resistance and stimulates metastasis in gastric, ovarian, and lung cancer [White and Muller, 2007; Shibue 
and Weinberg, 2009]. 11 and 21 integrins are key regulators of hepatocarcinoma cell invasion [Yang et al., 2003], 
and several integrins are up- (21, v3, 41, and IIb3) or down-regulated (61, v5) in melanoma [Kuphal et 
al., 2005]. 51 integrin, the fibronectin receptor, is involved in the malignant behaviour of colon carcinoma cells. 
Highly invasive colon cell lines, such as HCT-116 cells, express higher levels of 51 integrin than poorly invasive 
cells
 
[Janouskova et al., 2013]. 
Integrins activate many different intracellular pathways through the formation of protein-protein signalling complexes 
[DeMali et al., 2003; Mitra and Schlaepfer, 2006; Hood and Cheresh, 2002]. One of the early mediators of the integrin 
pathway is the intracellular focal adhesion kinase FAK. FAK activates downstream signalling cascades, such as the 
PI3K/Akt and MAPK/Erk pathways, implicated in the regulation of tumour cell proliferation, invasion, migration and 
survival [Ridley et al., 2003; Sieg et al., 2000]. FAK also mediates 51 integrin activation during the early stages of 
cell adhesion to ECM, inducing integrin clustering and increasing the number of bound integrin molecules [Michael et 
al., 2009; Sieg et al., 1999; Zeng et al., 2006].  
This study sets up an in vitro CRC model that, overcoming the bias implicit in the single cell cultures, aims to resemble 
the complex in vivo milieu run into by tumour invasive cells. In particular, it focuses on the behaviour of the highly 
invasive colon cancer cells HCT-116 inserted in the context of the liver microenvironment, here reproduced by both its 
structural components (i.e. ECM proteins) and the soluble factors secreted by the hepatocytes. The results demonstrate 
the straightforward effect of the microenvironment of the liver on cancer progression to metastases, in particular on the 
tumour cell adhesion and settlement process. These metastatic steps are favoured by the hepatic microenvironment 
through the modulation of the 51 integrin and the activation of its downstream signalling pathway molecule FAK. 
The ECM proteins synergize with the soluble factors secreted by the hepatocytes, driving the molecular events 
determinant for the adhesion of HCT-116 colorectal cancer cells to their favourite metastasis target organ.  
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2.  Materials and Methods 
 
2.1 Cell cultures 
 
The adenocarcinoma colon cancer cell line HCT-116 was kindly supplied by the group of dr. C. Gaiddon, University of 
Strasbourg, France. The cell line was cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Euroclone, Ltd., UK) 
supplemented with 10% foetal bovine serum (FBS; Gibco-Invitrogen Corp., UK), 2 mM L-glutamine (Euroclone Ltd., 
UK), 100 IU/ml penicillin, 100 μg/ml streptomycin solution (Euroclone Ltd., UK). 
The human immortalized hepatocytes cell line IHH was kindly supplied by the group of prof. C. Tiribelli, CSF, 
University of Trieste, Italy. The cell line was cultured in 1:1 DMEM/HAM’s F12 medium supplemented with 10% 
FBS, 2 mM L-glutamine, 100 IU/ml penicillin, 100 μg/ml streptomycin solution, dexamethasone 10-4 M (SIGMA-
Aldrich
®
, MO, USA), pancreatic bovine insulin 10
-8 
M (SIGMA-Aldrich
®
, MO, USA), Hepes Buffer 1 M (SIGMA-
Aldrich
®
, MO, USA). 
The human kidney cell line HK-2, a proximal tubular cell (PTC) line derived from normal kidney, was supplied by prof. 
R. Bulla (Department of Life Sciences, University of Trieste). The cell line was cultured in 1:1 DMEM/HAM’s F12 
medium supplemented with de-complemented FBS 5%, antibiotics (100 IU/ml penicillin, 100 μg/ml streptomycin), 2 
mM L-glutamine, 5 mg/ml insulin from bovine pancreas, 5 mg/ml holo-transferrin, 5 ng/ml sodium selenite, 5 ng/ml 
hydrocortisone, ng/ml EGF 10, 5 pg/ml T3, and 5 pg/ml PGE1 (SIGMA-Aldrich
®
, MO, USA).  
The cell lines were grown in a CO2 incubator with 5% CO2 and 100% relative humidity at 37°C. Once 90% of 
confluence was reached, the cell lines were detached with trypsin/EDTA solution (0.05% trypsin, 0.02% EDTA in PBS, 
SIGMA-Aldrich
®
, MO, USA). Cell viability was determined by the trypan blue dye exclusion test. 
 
 
2.2 IHH (H-CM) and HK-2 (HK-CM) conditioned medium preparation 
 
The H-CM medium was obtained culturing IHH cells at approximately 70 - 80% of confluence in their standard 
medium for 24 h, afterwards it was collected and stored at -20°C until use. 
The same procedure was followed to prepare HK-CM medium from HK-2 cell line.  
 
2.3 Invasion Assay 
 
Invasion assay was performed using 8.0 m pore size Transwell inserts (Costar, Cambridge MA, USA) coated with 
Matrigel™ (600 mg/ml) at room temperature overnight. HCT-116 cells were incubated with serum-free medium 24 h 
before seeding them on inserts (50,000 cells/insert). HCT-116 (ST-M), IHH (H-M) and IHH conditioned medium (H-
CM) were added in the lower chambers of the plate. The basal invasion rate, i.e. not induced by the presence of FBS in 
the attracting medium, was measured. 
After 96 h at 37°C, cells remained on the upper side of the membrane were removed using cotton swabs, while the cells 
that migrated to the underside were fixed in glutaraldehyde 1.1% (v/v) at room temperature for 15 minutes, and then 
stained with crystal violet solution 0.1% (w/v) for 20 minutes; after washing to remove unreacted reagent, the dye was 
solubilized in acetic acid 10% (v/v) [Kueng et al., 1989]. The absorbance units were read at 590 nm and related to cell 
invasion rate. Each assay was done in triplicate and data presented as mean with the standard deviation.  
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2.4 Adhesion assay 
 
A 96-well plate was pre-coated with fibronectin, collagen I, collagen IV, poly-L-lysine (SIGMA-Aldrich
®
, MO, USA,), 
laminin (SIGMA-Aldrich
®
, MO, USA) or Matrigel™ (20 mg/ml) for 4 h at 37°C or at 4°C overnight and subsequently 
blocked with PBS-BSA 0.1% (w/v) for 15 min at 37°C. Sub-confluent tumour cells were incubated 24 h in ST-M, H-M 
and H-CM medium, and then in serum-free medium for additional 24 h. The same procedure was followed to perform 
the adhesion assay in the presence of medium conditioned by the human renal cell line HK-2 (HK-M and HK-CM).  
Cells were trypsinized with 1 mM EDTA, re-suspended in serum free medium with 0.1% BSA for 30 minutes at room 
temperature to ensure re-expression of adhesion receptors on the cell surface and seeded in the plate (20,000 cells/well). 
HCT-116 were allowed to attach to each substrate for 1 h at 37°C and the non-adherent cells removed by washing. The 
adherent cells were fixed with trichloro-acetic acid 10% (v/v) for 1 h at 4°C and stained with sulphorodamine B 0.4% 
(w/v) according to the method of Skehan et al. [Skehan et al., 1990]. The absorbance units were read at 570 nm and 
related to the adhesion rate. 
For the adhesion assay in the presence of 51 function blocking antibody, tumour cells were re-suspended in PBS 
with or without 5 g/ml of the antibody JBS5, (Millipore, MA, USA) and then plated as described above. The adhesion 
assays were repeated for each condition in quadruplicate for three times. The results shown represent the mean with the 
standard error of one representative experiment out of the three performed. 
 
2.5 Integrin profile analyses 
 
Sub-confluent tumour cells were incubated 24 h in ST-M, H-M and H-CM medium, and then detached with 1mM 
EDTA, re-suspended in serum free medium with 0.1% BSA for 30 minutes at room temperature to ensure re-expression 
of adhesion receptors on the cell surface. Integrin expression levels were analyzed using an integrin mediated cell 
adhesion fluorimetric array (Chemicon International, ECM 535). Integrin array kit recognizes extracellular epitopes of 
human α chains (α1, α2, α3, α4, α5, αV, and αVβ3) and β chains (β1, β2, β3, β4, β6, αVβ5, α5β1) of integrins. In this 
kit, the wells of a 96 well plate contain immobilized monoclonal human integrin antibodies used to capture cells 
expressing integrins on their surface. Cells were re-suspended in DMEM medium and left adhere to the plates 1 h at 
37°C and 5% CO2. Unbound cells were washed off, cells adherent on the plate were lysed with the cell lysis buffer 
included in the kit, and integrins were detected using the molecular probe CyQuant GR dye. Fluorescence was 
determined at 540-570 nm on a microtiter plate reader (FluoroCount
TM
, Packard). The experiment was repeated for each 
condition in triplicate, two times. The results shown represent the mean with the standard error of the two experiments 
performed. 
 
2.6 Flow Cytometric Analyses of 51 cell surface expression 
 
Sub-confluent tumour cells were incubated 24 h in ST-M, H-M and H-CM medium, and then in serum-free medium for 
additional 24 h. Cells were trypsinized with 1 mM EDTA and re-suspended in serum free medium with 0.1% BSA for 
30 minutes at room temperature. Cells (500,000/sample) were then centrifuged and incubated with an anti-51 
primary antibody (clone HA5 5 g/ml, Millipore, MA, USA) in PBS for 30 minutes at 4°C. Cells were then centrifuged 
and incubated with a FITC-conjugated goat anti mouse GAM-antibody (diluted 1:100, SIGMA-Aldrich
®
, MO, USA) in 
PBS for 30 minutes at 4°C. After centrifugation cells were re-suspended in PBS-0.1% BSA (w/v)- 0.1% NaN3 (w/v) 
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and analysed at flow cytometer (FACS Calibur cell analyser, Becton Dickinson, Milano, Italy). For each sample 10,000 
events were recorded. 
Data obtained were processed using WinMDI 2.9 software. 
The same analyses were performed on HCT-116 cells pre-adhered on fibronectin (20 mg/ml) for 1 h at 37°C before 
51 integrin expression detection.  
The analyses were repeated for each condition in triplicate, three times. The results shown represent the mean with the 
standard deviation of the three analyses performed. 
 
2.7 Western blot analyses of FAK activation 
 
Sub-confluent HCT-116 cells were incubated 24 h in ST-M, H-M and H-CM medium and then in serum-free medium 
for additional 24 h; cells were then detached with PBS-EDTA 1 mM, incubated in serum free medium with 0.1% BSA 
for 30 minutes at room temperature and seeded on a 6-well plate (1x10
6
/well) pre-coated or not with fibronectin (20 
mg/ml). 
Cells were allowed to adhere for 1 h at 37°C, then detached with Trypsin/EDTA and lysed with the lysis buffer (0.5% 
Na-deoxycholate, 1% Igepal, 50 mM HEPES, 150 mM NaCl, 1 mM Na-orthovanadate, 50 mM NaF, 20 mM -
glicerophosphate, 0.1 M okadaic acid, 1 mM PMSF, 50 g/ml leupeptine, 20 g/ml aprotinin, 10 mM pepstatin). Total 
protein extract was quantified following the method of Bradford [Bradford, 1976]. 
Proteins in the total cell lysate (10 g of extract for FAK detection and 30 g for P-FAK detection) were separated on 
8% polyacrylamide SDS-PAGE and electro-transferred to a nitrocellulose membrane (Bio-Rad, Milano, Italy). 
Afterwards, the blot was blocked in a solution of 5% skimmed milk, 0.1% tween in TBS for FAK detection, or in a 
solution of 3% BSA, 0.1% Tween in TBS for P-FAK detection for 1 h at room temperature. Membrane-bound proteins 
were probed with an anti-FAK primary antibody (#3285 Cell Signalling, Milano, Italy, 1:1000) and an anti-P-Y397-
FAK primary antibody (#3283 Cell Signalling, Milano, Italy, 1:1000) over night at 4°C and then washed before 
incubation with a horseradish peroxidase-conjugated secondary antibody (#7074 Cell Signalling, Milano, Italy, 1:1000) 
for 1 h at room temperature in agitation. Proteins were detected incubating membranes with horseradish substrate (Cell 
Signalling, Milano, Italy) and developed with appropriate reagents and Kodak autoradiography film (Amersham 
Pharmacia Biotech, NJ, USA).  
 
2.8 Western blot analyses of 51 - 21 cross-talk 
 
Sub-confluent HCT-116 cells were incubated 24 h in ST-M, H-M and H-CM medium and then in serum-free medium 
for additional 24 h; cells were then detached with PBS-EDTA 1 mM, incubated in serum free medium with 0.1% BSA 
for 30 minutes at room temperature and seeded on a 6-well plate (1x10
6
/well) pre-coated with collagen I (20 mg/ml). 
Cells were allowed to adhere for 1 h at 37°C, then detached with Trypsin/EDTA and lysed with the lysis buffer (0.5% 
Na-deoxycholate, 1% Igepal, 50 mM HEPES, 150 mM NaCl, 1mM Na-orthovanadate, 50 mM NaF, 20 mM -
glicerophosphate, 0.1 M okadaic acid, 1 mM PMSF, 50 g/ml leupeptine, 20 mg/ml aprotinin, 10 M pepstatin). Total 
proteins extract was quantified and western blot analyses (40 g of total protein extract) performed as previously 
described.  
For 21 integrin identification an anti-2 primary antibody was used (AB1936 Millipore, 1:1000). 
 
2.9 Real Time PCR for 5, 1, and FAK expression 
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The differential expression of the 5, 1, and FAK genes in HCT-116 cells grown 24 h in ST-M, in H-M, and in H-CM 
was analysed by real time PCR. RNAs were reverse-transcribed with a qScript™ cDNA Synthesis Kit (Quanta 
Biosciences, Gaithersburg, MD, USA) according to the manufacturer’s protocol. Expression levels were determined by 
real time PCR on a CFX96 system (Bio-Rad, Hercules, CA, USA). The 15 mL reaction mix included 7.5 mL of 2x 
SsoAdvanced™ SYBR Green® Supermix (Bio-Rad), 0.3 mL of each 10 mM primer and 2 ml of a 1:20 cDNA dilution. 
The following thermal profile was used: an initial 30” denaturation step at 95°C, followed by 40 cycles at 95° for 5” 
and 58° for 30”. Amplification products were analyzed with a 65°/95°C melting curve. The following 5, 1, and FAK 
primer pairs were designed using the MIT Prime3 online primer design protocol from the relative gene sequence: for 
FAK 5’-TGA CCC CAA CTT GAA TCA CA-3’ (forward) and 5’-CCA GGT GGT TGG CTC ACT AT-3’ (reverse); 
for ITGA5 (5-integrin subunit) 5’-GTG GGC CAA CAA AGA ACA CT-3’ (forward) and  5’-TGA GTT CTG ATT 
CCC CTT GG-3’ (reverse); for ITGB1 (1-integrin subunit) 5’-CCC TTG CAC AAG TGA ACA GA-3’ (forward) and 
5’-CCA CCT TCT GGA GAA TCC AA-3’ (reverse). 
RPL5, a highly stable housekeeping gene, was chosen for normalization, and amplified using 5′-
GCACACGAACTGCCAAAATA-3′ (forward) and 5′-TTCATCACCAGTCACCTCCA-3′ (reverse) primers. The 
expression levels of the selected transcripts were determined using the comparative Ct method (2-DD Ct method) 
[Livak and Schmittgen, 2001]. Ct values used for quantification were corrected based on PCR efficiencies using 
LinRegPCR [Ramakers et al., 2003]. Results are given as the mean with standard deviation of three technical replicates.  
 
2.10 Statistical analysis 
 
Results obtained were processed using InstatGraph3 software and presented as mean  standard deviation. The group 
means were compared using a Two-Way Analysis of Variance (ANOVA) followed by t-test, or Tukey-Kramer post-test 
and considered significant when p < 0.05. 
 
 
3.          Results 
3.1  The hepatic microenvironment affects HCT-116 cell invasion 
The effects of the hepatic microenvironment soluble factors on the basic invasion potential of HCT-116 colorectal 
cancer cells were analysed using a medium conditioned by the IHH hepatocyte cell line (H-CM), in comparison to the 
same fresh medium, not exposed to the IHH hepatocytes (H-M), and to the standard culture medium of HCT-116 cells 
(ST-M)  (Fig.1). 
When cultured in the presence of ST-M, HCT-116 cells showed a basic, i.e. not FBS-induced, efficiency to invade the 
Matrigel barrier. When the stimulus was given by the H-M medium, the invasive ability of HCT-116 cells was 
comparable to that observed under the standard condition of ST-M. On the contrary, the hepatocyte conditioned 
medium H-CM significantly increased the invasion rate of these cells (+ 41% vs H-M and + 64% vs ST-M, 
respectively), suggesting that the soluble factors secreted by hepatocytes can act as invasion inductors. 
 
3.2   The hepatic microenvironment affects HCT-116 cell adhesion 
 
The HCT-116 cells showed a significantly increased adhesion potential when they were grown in vitro on fibronectin 
and laminin, for 24 h in H-M medium in comparison to the standard medium ST-M (Fig.2a). The adhesion rate to 
fibronectin and collagen I, two proteins largely represented in the liver ECM, further increased when tumour cells were 
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grown in the H-CM medium (+ 37%  4 and + 35%  11 versus ST-M, respectively for fibronectin and collagen I), 
suggesting the synergy between the structural components and the soluble factors of the hepatic microenvironment (H-
M versus H-CM on both substrates: p < 0.05). 
The adhesion of HCT-116 to ECM substrates was also tested in the presence of a medium (HK-M) conditioned for 24 h 
by the human renal cell line HK-2 (HK-CM). HK-M increased the adhesion of HCT-116 cells to all ECM proteins 
examined, likely because of the presence in this medium of many factors promoting cell growth, metabolism and 
functions. The consumption of the same factors, during the conditioning by HK-2 cells, is supposed to be the reason of 
the lack of a similar effect of HK-CM on the HCT-116 cells (Fig.2b). These data allow us to credit the liver 
microenvironment with a specific pro-adhesive effect, and particularly the soluble factors released by the hepatocytes 
during this step of the metastatic dissemination of CRC cells. 
  
3.3    The hepatic microenvironment modulates HCT-116 integrin profile 
 
Considering the changes of cell adhesion potential influenced by the microenvironment, the integrin expression profile 
of HCT-116 cells cultured in ST-M, H-M and H-CM mediums, was investigated measuring the cell membrane 
expression of several alpha and beta chains as well as of some fully assembled integrins. The integrin profile of HCT-
116 cells grown in standard medium was in line with the adhesion potential shown in the previous experiment: the high 
expression of the alpha 2, 3 and 5 chains together with the beta 1 chain (Fig.3) reflected the preferred adhesion of HCT-
116 cells respectively to collagen I, laminin and fibronectin. In fact, 21, 31 and 51 are the main integrins 
mediating the cell interactions to the ECM substrates mentioned above. Interestingly, we detected the absence of the 
v3 integrin that, together with 51, usually manages cell-fibronectin interactions [Schaffner et al., 2013].  The 
results showed that the medium conditioned by the hepatocytes significantly reduced the expression of the 1, 2 and 
3 chains in the HCT-116 cells. These changes of the integrin profile cannot explain the increased adhesion of HCT-
116 to ECM proteins measured when cells are cultured in H-CM medium. These data highlight the fundamental role of 
the ECM, modulating cancer cell features and inducing the expression of specific integrins, the levels and/or activity of 
which can influence tumour cell behaviour during the disease progression. 
 
3.4     The hepatic microenvironment affects 51 activation in HCT-116 cells 
 
The relevance of 51 integrin for HCT-116 cell adhesion to fibronectin, was confirmed with the use of a 51 
function blocking antibody. As expected, HCT-116 colon carcinoma cells drastically reduced (by 60–80%) their 
adhesion to this substrate, independently of the culture medium used (compare Fig 4 Fibronectin, absence (-) to 
presence (+) of blocking antibody). Interestingly, this assay unveiled also the basic role of 51 integrin for HCT-116 
cell adhesion to collagen I and IV in the hepatic microenvironment. The anti-51 integrin blocking antibody 
significantly reduced the adhesion rate of HCT-116 cells on both substrates, depending on the contemporary presence 
of the structural components of the ECM and the soluble factors released by the hepatocytes cultured in the conditioned 
medium (H-CM (+) versus H-CM (-) on collagen I and IV: p < 0.001). 
The soluble factors secreted by IHH hepatocytes in the conditioned medium and fibronectin did not affect the density of 
51 integrin receptors on the surface of HCT-116 cells (Mean Fluorescence Intensity, MFI) (Fig.5a), or the 
percentage of cells positive to the receptor (data not shown).  
Western blot analyses supported the hypothesis that FAK regulates cell adhesion strengthening via integrin activation. 
Comparing FAK levels of HCT-116 cells grown in H-CM medium to those of its Y397-phosphorylated form, the rate 
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of the phosphorylated FAK is increased in comparison to the same test performed using ST-M (+ 126%  19, p < 
0.001) and H-M (+ 97%  27, p < 0.05) (Fig.5b). This result was obtained when cells were allowed to adhere to 
fibronectin-coated wells, emphasizing the need of the presence of this ECM protein, particularly abundant in the liver 
matrix, for the settlement of CRC cells in the metastasis target organ. 
 
3.5 The activation of 51 and FAK is regulated by the hepatic microenvironment at the post-translational level 
 
The quantitation of the expression levels of the gene FAK, by real time PCR experiments, in HCT-116 cells grown in 
different media and adhered to fibronectin, suggested an up-regulation of the gene induced by the H-M medium respect 
to the ST-M medium. The activity of H-CM medium compared to that of the H-M medium was reduced, even though it 
increased the expression of FAK. This effect did not reflect what happens at the protein level, where the activation of 
the protein FAK was higher in HCT-116 cells grown in H-CM compared to the other media tested, and supported the 
hypothesis of the post-translational modulation guided by the hepatic microenvironment, rather than of a direct effect at 
the transcriptional level (Fig.6).  No relevant differences in the expression levels of 5 and 1 genes, induced by the 
different media tested, were detected (data not shown). 
 
3.6 The hepatic microenvironment stimulates the cross-talk between 51 and 21 integrins  
 
When 51 activity of HCT-116 cells was blocked by a specific antibody, western blot analyses revealed a remarkable 
reduction of the 21 protein level caused by the combined action of soluble (H-CM) and structural (collagen I) 
constituents of the hepatic microenvironment (Fig.7). 
 
4. Discussion 
 
The progression of colorectal cancer to secondary tumours represents the critical point in patient’s survival 
[www.nlm.nih.gov/medlineplus/cancers.html]. It is increasingly recognized that disease progression is influenced by the 
bi-directional communication between tumour cells and their microenvironment, whose interactions determine disease 
initiation and progression, and consequently patient’s prognosis [Joyce and Pollard, 2009]. This also means that cancer 
is a heterogeneous disease also by virtue of the composition and content and/or activation state, of the 
microenvironment-derived stromal cells [Balkwill and Mantovani, 2001; Hanahan and Coussens, 2012]. 
We report here on the events involved in the liver colonization by CRC cells, focusing on the role of the 
microenvironment, represented by the structural components (ECM proteins) and by the soluble factors secreted by the 
hepatocytes, on the step of cell settlement and adhesion, a crucial event for metastasis formation. The aim was to set up 
an in vitro model of CRC metastasis depicting, more closely than a conventional cell culture, the in vivo hepatic 
metastatic niche that tumour cells face during their liver colonization.  
Under the influence of the medium enriched of soluble factors secreted by the hepatocytes, the HCT-116 cells increase 
their adhesion to fibronectin and collagen I, two ECM proteins particularly abundant in the liver matrix during 
pathological processes such as fibrosis and cancer [Cutroneo et al, 2006; Kershenobich Stalnikowitz and Weissbrod, 
2003]. The absence of similar effects of the medium conditioned by renal cells, as well as of the medium conditioned by 
the HCT-116 cells themselves on the adhesion profile of HCT-116 cells to ECM (data not shown), allow us to attribute 
to the soluble factors released by the hepatic cells, and associated with specific ECM proteins, the increased adhesion of 
CRC cells. This result also stresses the fundamental contribution of the hepatic microenvironment to colon cancer 
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progression in this cellular model. Preliminary analyses, performed on the medium conditioned by the human 
hepatocytes IHH, revealed the increased presence of growth factors such as VEGF and of chemokines such as MCP-1, 
as some of the main components released by the cells in this medium (Chambery A et al., SUN, Italy, personal 
communication). 
It is known that integrins can interact with many different factors of the tumour microenvironment, determining 
important consequences on a number of intracellular processes, among which the adhesion of tumour cells to ECM, 
thus significantly affecting the invasive and metastatic tumour cell potential. Since integrins are linked to the 
cytoskeleton structures, their engagement triggers crucial signals for tumour cell migration and metastasis formation 
[Desgrosellier and Cheresh, 2010; Friedl and Alexander, 2011]. The fibronectin-cell interaction through 51 integrin 
triggers the auto-phosphorylation at Y397 site of the intracellular focal adhesion kinase FAK [Michael et al., 2009]. 
Quantitative relationships among integrin-ligand binding, adhesion, and signalling via FAK are also documented
 
[Asthagiri et al., 1999]. The presently reported results indicate that the IHH hepatocytes release molecules reinforcing 
the fibronectin-induced FAK auto-phosphorylation and, consequently, trigger the activation of this pathway, therefore 
inducing HCT-116 cells to adhere more avidly to fibronectin via 51 integrin.  
Our results are in line with other reports showing the need of integrin 51 tethering for Y397-FAK auto-
phosphorylation during the integrin signalling activation [Shi and Boettiger, 2003].  Our data also add a significant role 
to the hepatic microenvironment for the adhesion process of colorectal cancer cells (a fundamental step during 
metastasis formation), and show that the soluble factors of the metastatic niche are necessary to get a synergistic 
interplay with the ECM structural proteins. These findings add further knowledge in the mechanisms of CRC metastasis 
biology and confer reliance to the further development of this experimental model system. 
51 integrin is the leading actor during HCT-116 colorectal cancer cell dissemination to the liver, since cells use 
almost exclusively this molecule to adhere to fibronectin. In fact, v3 the other integrin mainly involved in cell-
fibronectin adhesion [Schaffner et al., 2013], is not significantly expressed on the surface of the HCT-116 cells. Based 
on the presented data, we observed that the microenvironment stimulates the activation of 51 integrin signalling 
pathway rather than modulates the expression of the protein or of its coding genes (no changes detected on the 5 and 
1 chains coding genes, data not shown). The role of the hepatic microenvironment seems to intervene on FAK at the 
post-translational level, since changes of its gene expression levels in the HCT-116 cells grown in H-CM medium and 
on fibronectin, are not in agreement with the increased activation (i.e. phosphorylation) of the protein FAK measured in 
WB. Furthermore, the reduced effect of the H-CM medium and fibronectin on FAK gene expression, compared to the 
level of the up-regulation induced by the H-M medium on the cells cultured on the same substrate, could be attributed 
to specific hepatic factors released in the H-CM medium which interfere and reduce the stimulating effect of the hepatic 
non conditioned medium (H-M medium) on the transcription of the FAK gene. 
The impact of the metastatic microenvironment on the role of 51 integrin in the settlement of HCT-116 CRC cells in 
the liver seems to be even more important if we consider the results obtained with collagen I, the other main ECM 
protein present in the liver matrix. The synergistic interplay of H-CM and collagen I on the adhesion of HCT-116 cells 
resembles that detected on fibronectin and, similarly, it is strongly reduced in the presence of an anti-51 integrin 
blocking antibody. In the present CRC model, the hepatic microenvironment seems to affect 51 integrin behaviour 
inducing an integrin crosstalk event, where the binding of one integrin type (transducer) alters the behaviour of a 
different integrin type on the same cell by coordinating its activation and availability
 
[Friedrichs et al., 2010]. This event 
influences the adhesion of HCT-116 colorectal cancer cells to other ECM substrates beside fibronectin. The 21 is the 
main integrin designated for the cell-collagen I interaction [Leitinger, 2011]. Although the role of 21 integrin in CRC 
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is still controversial, it was already proved that the interactions of α5β1 with fibronectin, and that of α2β1 with type I 
collagen showed a combined effect on the downstream cellular signals [Reyes et al., 2008]. In our model, the 
engagement of 51 integrin seems to trigger 21 integrin, since the functional block of the former leads to the 
complete suppression of the expression of the second. Therefore 51 and 21 integrins cooperate together to sustain 
CRC adhesion and progression to the liver. In line with the oncogenic role of 21 integrin, the block of its activity 
inhibits CRC migration [Robertson et al., 2009]; moreover, van der Bij et al. reported that blocking 2 integrins 
prevented liver metastases outgrowth of a rat colon carcinoma model
 
[van der Bij et al., 2008].  
Due to their implication in several cellular functions, including the initiation, progression and metastasis of solid 
tumours, integrins are emerging as an appealing target for the setting up of anti-tumour and anti-metastatic strategies 
[Millard et al., 2011]. The 51 integrin is claimed to be a pertinent therapeutic target in solid tumours [Schaffner et al., 
2013], and to control the progression of experimental lung cancer
 
[Roman et al., 2010]. Many authors propose 51 
integrin as a therapeutic target also for CRC and, in particular, for the treatment of liver metastases [Kuphal et al., 2005; 
Robertson et al., 2008]. Novel strategies are also directed to molecules of the signalling pathways engaged by 51 
integrin, such as FAK. The FAK inhibitor PND-1186 blocks Y-397-FAK phosphorylation in vivo and decreases tumour 
growth and spontaneous breast to lung metastasis in pre-clinical models [Walsh et al., 2010]. Several other ATP-
competitive small molecule inhibitors of FAK have been developed and proved to be active in diverse tumour types, 
colon cancer included [Slack-Davis et al., 2007; Roberts et al., 2008; Shi et al., 2007; Liu et al., 2007; Slack-Davis et 
al., 2009]. 
 
5. Conclusions 
This study shows how the microenvironment behaves as a crucial actor in the CRC metastatic process and describes an 
in vitro model system reproducing the hepatic metastatic niche, thus depicting, more closely than a simple cell culture, 
the in vivo milieu that tumour cells face during their liver colonization. The hepatic microenvironment drives the 
settlement of CRC cells into the liver by modulating the activity of 51 integrin and its signalling pathway, which 
master role in this process is significantly enhanced by the soluble components and by the structural proteins of the liver 
microenvironment. In addition, this study indirectly suggests the potential impact of the targeting of 51 integrin for 
other oncogenic integrins, such as 21 and for their role in liver cell invasion and dissemination. In short, these data 
highlight the importance of evaluating the influence of the hepatic microenvironment on these pathways to develop new 
drugs directed to the selective control of CRC liver metastases. 
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Legends   
 
 
Figure 1. Effects of the hepatic microenvironment on basal HCT-116 cell invasion. HCT-116 cells were sown on 
the top compartment of invasion inserts coated with Matrigel (600 μg/ml), and left to invade against stimuli 
represented by the standard culture medium (ST-M), the IHH hepatocytes culture medium (H-M), and the IHH 
hepatocytes conditioned culture medium (H-CM).  Data represent cells that had completely passed through the 
Matrigel-coated barrier after 96 h. Data are mean ± SD of Absorbance Units of three independent experiments, each 
with triplicate sets. Statistical analysis: ANOVA and Tukey-Kramer post-test: ** p < 0.01 versus ST-M; ° p < 0.05 
versus H-M. 
 
Figure 2. Influence of different media on the adhesion of HCT-116 cells to ECM components. a) HCT-116 cells 
grown for 24 h in ST-M, H-M and H-CM, were seeded into 96-well plates pre-coated with different ECM components, 
and allowed to adhere 1 h at 37°C 5% CO2. Adherent cells were then fixed and stained with sulphorodamine B. The dye 
was then solubilized and the absorbance units read at 570 nm. b) HCT-116 cells grown for 24 h in ST-M, HK-M and 
HK-CM, were seeded into 96-well plates pre-coated with different ECM components and treated as described above. 
Data are mean ± SE of Absorbance Units of one experiment representative of the three independent experiments 
performed, each with quadruplicate sets. Statistical analysis: ANOVA and Tukey-Kramer post-test: * p < 0.05, ** p < 
0.01, and *** p < 0.001 versus ST-M on the same substrate; ° p < 0.05, °° p < 0.01, and °°° p < 0.001 versus H-M (a) or 
HK-M (b) on the same substrate. 
 
Figure 3. Integrin profile of HCT-116 cells. 
Integrin profile of HCT-116 cells grown for 24 h in ST-M, H-M and H-CM medium. Cells were then detached with 
1mM EDTA, re-suspended in serum-free medium with 0.1% BSA for 30 minutes at room temperature to ensure re-
expression of adhesion receptors on the cell surface prior to seed them on the functionalized 96 well plates. The Integrin 
array kit recognizes extracellular epitopes of human α (α1, α2, α3, α4, α5, αV, and αVβ3) and β (β1, β2, β3, β4, β6, 
αVβ5, α5β1) integrins. Cells were left adhere to the plates 1 h at 37°C 5% CO2. Unbound cells were washed off; 
adherent cells on the plate were lysed with cell lysis buffer, and integrins were detected using the molecular probe 
CyQuant GR dye. Fluorescence was determined at 540-570 nm on a microtiter plate reader. The results represent the 
mean ± SE of the Relative Fluorescence Units of the two experiments performed. The dashed line around 40000 RFU 
indicates the fluorescence of the negative control in the assay. Statistical analysis: ANOVA and Tukey-Kramer post-
test: * p < 0.05, ** p < 0.01, and *** p < 0.001 versus ST-M; ° p < 0.05, and °° p < 0.01 versus H-M. 
 
Figure 4. 51 integrin dependence of HCT-116 cell adhesion to ECM components. HCT-116 cells grown 24 h in 
ST-M, H-M and H-CM were seeded into 96-well plates pre-coated with different ECM substrates without (-) or with 
(+) an anti-51 integrin blocking antibody, and allowed to adhere 1 h at 37°C 5% CO2. Adherent cells were then fixed 
and stained with sulphorodamine B. The dye was then solubilized and the absorbance units read at 570 nm. Data are 
mean ± SD of the Absorbance Units of three independent experiments, each with quadruplicate sets. Statistical analysis: 
ANOVA and Tukey-Kramer post-test: * p < 0.05, ** p < 0.01, and *** p < 0.001 versus ST-M and ° p < 0.05, °° p < 
0.01, and °°° p < 0.001 versus H-M, within groups without (-) or with (+) anti-51 integrin blocking antibody; §§§ p < 
0.001 versus the same medium without (-) anti-51 integrin blocking antibody. 
 
Figure 5. Influence of the hepatic microenvironment on 51 integrin expression and on FAK activation in 
HCT-116 cells. a) HCT-116 cells grown 24 h in ST-M, H-M and H-CM were seeded into 6-well plates pre-coated or 
not with fibronectin, and allowed to adhere 1 h at 37°C 5% CO2. Adherent cells were harvested, incubated with an anti-
α5β1 primary antibody, followed by incubation with a FITC-labelled secondary antibody, and then analysed by flow 
cytometry. Data are mean ± SEM of the Mean Fluorescence Units of two independent experiments, each with triplicate 
sets. b) HCT-116 cells grown 24 h in ST-M, H-M and H-CM were seeded into 6-well plates pre-coated or not with 
fibronectin, and allowed to adhere 1 h at 37°C 5% CO2. Adherent cells were harvested, and their total protein content 
extracted. Equal amounts of total proteins from each sample were subjected to immune-blotting and then probed with 
antibodies against FAK and P-Y397-FAK. Western blots analyses and quantitation of Western blot lanes, by using 
ImageJ software, of one representative experiment out of three, are displayed. Data shown in (b) lower panel are the 
ratio between P-Y397-FAK and FAK levels, after normalization to -actin amount in the same sample. This ratio 
calculated for HCT-116 cells grown in ST-M in each substrate was set equal to 1. Statistical analysis: ANOVA and 
Tukey-Kramer post-test: ** p < 0.01 versus ST-M; ° p < 0.05 versus H-M on the same substrate. 
 
Figure 6. Influence of the hepatic microenvironment on the expression level of the FAK gene in HCT-116. HCT-
116 cells grown 24 h in ST-M, H-M and H-CM were seeded into 6-well plates pre-coated or not with fibronectin, and 
allowed to adhere 1 h at 37°C 5% CO2. Adherent cells were harvested, and their total RNA content extracted. Then, a 
This article is protected by copyright. All rights reserved 16 
copy of cDNA was obtained by retro-transcription and subjected to real time RT-PCR. The expression levels of the 
gene FAK were normalised to the expression of the housekeeping gene RPL5. Data represent the mean  SD of three 
independent experiments, and are the ratio between the basal expression of mRNA in HCT-116 grown in H-M, or in H-
CM medium, to the basal expression of mRNA in HCT-116 grown in ST-M. This ratio calculated in HCT-116 cells 
grown in H-M in absence of fibronectin was set equal to 1. Statistical analysis: ANOVA and Tukey-Kramer post-test: 
*** p < 0.001 versus ST-M; °°° p < 0.001 versus H-M on the same substrate. 
 
Figure 7. Induction of a cross-talk between 51- and 21-integrins by the hepatic microenvironment. HCT-
116 cells grown 24 h in ST-M, H-M and H-CM were seeded into 6-well plates pre-coated or not with collagen I with 
(treated) or without (untreated) an anti-51 integrin blocking antibody, and allowed to adhere 1 h at 37°C 5% CO2. 
Adherent cells were harvested, and their total protein content extracted. Equal amounts of total proteins from each 
sample were subjected to immune-blotting and then probed with an antibody against 21 integrin. Western blots 
analyses (a), and quantitation of Western blot lanes by using ImageJ software (b), of one representative experiment out 
of three, are displayed. Data shown in panel (b) are normalized for -actin amount in the same sample. The ratio 
between 21 and -actin expression in HCT-116 in ST-M was set equal to 1. Statistical analysis: ANOVA and Tukey-
Kramer post-test: * p < 0.05 versus ST-M; ° p < 0.05 versus H-M + blocking antibody; §§ p < 0.01 versus H-M without 
blocking antibody. 
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